 |
 |
|
|
| |
Product
/ Service |
Awards
/ Accreditations |
|
 |
The Company Awards |
- "Corporate Social Responsibility Awards" by China Association of Medical and Pharmaceutical Enterprises and People’s Daily in September 2008
- Due to the Group’s impress performance in operational management and quality control, Golden Meditech was awarded the prestigious" 10th International Convention Century Quality ERA Award (CQE)" held in Geneva in March 2008
- To acknowledge the Group’s sound business operations and promising growth, respected Hong Kong financial magazine, the Economic Digest selected Golden Meditech again as one of the "Outstanding Enterprise in Hong Kong" in Decemeber 2007.
- Selected by Forbes as one of the 200 "Best Under a Billion companies. Forbes Asia 30 October 2006 issue.
- Ranked by Yazhou Zhoukan as one of the "Chinese Business 500"--one of the best 500 listed Chinese companies worldwide. Yazhou Zhoukan 8 October 2006 issue.
- Ranked by Deloitte as one of Asia Pacific’s top 500 fastest-growing technology companies by "Deloitte Technology Fast 500 Asia Pacific 2005" program, which recognises Technology, Media and Telecommunications companies with the fastest annual revenue growth in Asia-Pacific region during the past three years
- Selected as "Best Investor Relations," small cap company, by AsiaMoney magazine, Dec 2004 - Jan 2005 issue.
|
|
 |
Autologous Blood Recovery System |
- Obtained China’s State Food and Drug Administration ("SFDA") approval in 2000
- The first PRC-manufactured product of its kind approved by the SFDA
- Nationwide Science & Technology Advancement Award, Second Class
- Beijing Science & Technology Award, First Class
- Top Ten Patented New Product of Technological Importance in Beijing
- Focal New Product for Nationwide Promotion
|
|
| |
Cord
Blood Bank |
- In recognition of the outstanding performance of the blood stem cells storage service, Golden Meditech was, once again, honoured by Deloitte Touche Tohmatsu as one of the 50 fastest growing hi-tech companies in China in October 2007, and as one of the 500 fastest growing hi-tech companies in the Asia Pacific region in December 2007.
- Selected by Deloitte in 2006 as one of the 50 fastest growing hi-tech companies in China and one of the 500 in the Asia-Pacific region.
- Granted the first Umbilical Cord Blood Stem Cell Storage Permit by China’s Ministry of Health in late 2002
- Holds two of the four Permits granted
|
|
| |
TangHerb® |
|
|
| |
HIFU
tumour therapy device |
|
|
| |
ECLIA System |
|
|
| |
|
|
|
|
|
 |
|
|
|
|
|